Clinical Endpoint Study of Ivermectin 0.5% Lotion
Clinical trial NCT03301649 · COMPLETED
Trial details
- NCT number
- NCT03301649
- Sponsor
- Actavis Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-07
- Primary completion
- 2018-03-12
- Enrollment
- 905
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.